Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 022394/0894 | |
| Pages: | 2 |
| | Recorded: | 03/13/2009 | | |
| Attorney Dkt #: | 104072.60646US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12323073
|
Filing Dt:
|
11/25/2008
|
|
Publication #:
|
|
Pub Dt:
|
07/02/2009
| | | | |
|
Title:
|
Treatment of Prostate Cancer with Angiogenesis-Targeting Quinazoline-Based Anti-Cancer Compounds
|
|
|
Assignee
|
|
|
|
|
| A144 ASTECC BUILDING |
| LEXINGTON, KENTUCKY 40506-0286 |
|
|
Correspondence name and address
|
| |
CROWELL & MORING LLP
|
| |
INTELLECTUAL PROPERTY GROUP
|
| |
P.O. BOX 14300
|
| |
WASHINGTON, DC 20044-4300
|
Search Results as of:
05/13/2024 06:40 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
